Dilated Cardiomyopathy (DCM)

Dilated cardiomyopathy is a primary disease of the heart muscle - the myocardium - where the muscle fibres degenerate and the heart chambers enlarge and thin. The weakened, enlarged heart pumps less effectively, reducing cardiac output and eventually leading to congestive heart failure.

DCM is the second most common acquired heart disease in dogs. Unlike MVD, which predominantly affects small breeds, DCM is a condition of large and giant breeds - Dobermanns, Great Danes, Irish Wolfhounds, Boxers, and Standard Poodles are most significantly affected. Dobermanns have an exceptionally high prevalence (estimated 50–58% of the breed will develop DCM).

The dangerous preclinical phase

DCM has an extended preclinical phase - the heart is structurally abnormal and the disease is progressing, but the dog shows no symptoms. During this phase, ventricular arrhythmias (dangerous irregular heartbeats) can develop and cause sudden death without any prior warning signs. This is why regular echocardiographic and Holter monitor screening in at-risk breeds is so important.

In Dobermanns: Annual echocardiography and 24-hour Holter monitoring from age four is recommended by the Dobermann Health Group. The same approach is recommended for all high-risk breeds from middle age.

What to monitor

Resting respiratory rate (RRR). As with MVD, the sleeping RRR is the most sensitive home indicator of developing heart failure. Log daily; the target is below 30 breaths per minute during sleep. A consistent rise above 30 warrants same-day vet contact.

Exercise tolerance. Note the distance and pace that causes the dog to tire. Declining exercise tolerance is an early sign.

Syncope (fainting). Sudden collapse during or after excitement or exercise in a large breed dog is a cardiac emergency. This may represent a dangerous ventricular arrhythmia.

Cough. A soft cough, particularly at night or at rest.

Appetite and weight. Cardiac cachexia (weight loss despite adequate food intake) is common in advancing DCM.

Rhythm. Some owners of Dobermanns learn to feel for irregular heart rhythm (pulse deficits) on the femoral artery. This is not something to rely on without training, but your vet can teach you what to feel for.

Arrhythmias and Holter monitoring

Ventricular arrhythmias - particularly ventricular premature contractions (VPCs) and ventricular tachycardia - are a major concern in DCM. In Dobermanns, arrhythmias may precede structural changes and can cause sudden cardiac death.

A 24-hour Holter monitor (a wearable ECG device attached to the dog for a day) records the heart rhythm continuously and can detect arrhythmias that would be missed on a brief clinic ECG. More than 50–100 VPCs per 24 hours in a Dobermann is significant; complex or fast arrhythmias are treated with antiarrhythmic medication.

Log any episodes of syncope, weakness, or unexpected lethargy - these may be arrhythmia episodes.

Treatment

Preclinical DCM with echocardiographic changes but no symptoms: Pimobendan has been shown to delay the onset of heart failure in dogs with occult DCM (Dobermann study: the PROTECT study). Treatment is increasingly recommended at this stage.

Arrhythmias: Mexiletine, sotalol, or amiodarone depending on arrhythmia type and breed. Treatment decisions are complex and often made by a cardiologist.

Heart failure: Pimobendan, diuretics, and ACE inhibitors - the same combination used for MVD in heart failure. Digoxin may be added for rate control.

When to contact your vet

Go to the emergency vet immediately if:

• Your dog collapses or faints
• Breathing is laboured or distressed
• Sudden acute deterioration

Contact your vet the same day if:

• RRR is consistently above 30
• Significant new exercise intolerance or weakness
• Cough has developed

Schedule routine screening for:

• Annual echocardiography and Holter monitoring in Dobermanns from age 4
• Biannual cardiac monitoring in other high-risk breeds from middle age

Frequently Asked Questions

My Dobermann has no symptoms - should they still be screened? Yes, absolutely. The most dangerous phase of DCM in Dobermanns is preclinical - arrhythmias can cause sudden cardiac death before any symptoms appear. Annual screening allows detection and treatment before this point.

What is the prognosis for a dog with DCM? It varies significantly with breed and stage at diagnosis. Preclinical dogs started on pimobendan at the appropriate stage have better outcomes. Once heart failure develops, median survival with treatment is typically 3–9 months, though some dogs live considerably longer with good management and monitoring.

Is DCM in dogs the same as the grain-free diet controversy? An FDA investigation in the US identified a possible association between DCM and grain-free (legume-heavy) diets in some dog breeds. The mechanism is not fully established, and the association remains under investigation. For at-risk breeds, discussing diet with your vet and not relying exclusively on grain-free legume-heavy formulations is reasonable. The heritable DCM in Dobermanns and giant breeds is distinct from this potential dietary association.

Can DCM be prevented? The genetic component in predisposed breeds cannot currently be prevented. Responsible breeding programmes in Dobermanns (the Dobermann Health Group Scheme) aim to reduce prevalence over time. For individual dogs, regular screening is the most important preventive action - catching and treating the disease early changes the outcome.

My dog has been diagnosed with DCM - should I see a specialist? Yes, for complex cases or Dobermanns. Veterinary cardiologists have expertise in DCM management, Holter interpretation, antiarrhythmic drug choices, and optimal echocardiographic monitoring intervals. Referral to a cardiologist is appropriate at any stage.